Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
East Mediterr Health J ; 7(4-5): 604-8, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-15332755

RESUMEN

The serological evidence of varicella zoster virus infection was determined among healthy individuals from infancy to 47 years of age living in this region. Of 648 people, 126 (19.4%) had no detectable antibody and were susceptible to infection. The overall adult seroprevalence rate was 81.3%. The rate among Emirati citizens increased with age; < 10 years, 45.8%; 11-20 years, 68.4%; 21-30 years, 89.5%; 31-40 years, 94.7%; and > 41 years, 88.9%. Adults from the Indian subcontinent and Philippines had variable prevalence rates and Sri Lankans living in the region were highly serosusceptible (35%). Because of the clinical impact of varicella in adult populations, vaccine prevention might be beneficial.


Asunto(s)
Varicela/epidemiología , Adolescente , Adulto , Distribución por Edad , Bangladesh/etnología , Varicela/sangre , Varicela/inmunología , Varicela/prevención & control , Vacuna contra la Varicela , Niño , Preescolar , Estudios Transversales , Susceptibilidad a Enfermedades , Emigración e Inmigración , Ensayo de Inmunoadsorción Enzimática , Humanos , India/etnología , Lactante , Persona de Mediana Edad , Pakistán/etnología , Filipinas/etnología , Vigilancia de la Población , Características de la Residencia , Factores de Riesgo , Estudios Seroepidemiológicos , Sri Lanka/etnología , Emiratos Árabes Unidos/epidemiología , Vacunación
2.
(East. Mediterr. health j).
en Inglés | WHO IRIS | ID: who-119063

RESUMEN

The serological evidence of varicella zoster virus infection was determined among healthy individuals from infancy to 47 years of age living in this region. Of 648 people, 126 [19.4%] had no detectable antibody and were susceptible to infection. The overall adult seroprevalence rate was 81.3%. The rate among Emirati citizens increased with age; < 10 years, 45.8%; 11-20 years, 68.4%; 21-30 years, 89.5%; 31-40 years, 94.7%; and > 41 years, 88.9%. Adults from the Indian subcontinent and Philippines had variable prevalence rates and Sri Lankans living in the region were highly serosusceptible [35%]. Because of the clinical impact of varicella in adult populations, vaccine prevention might be beneficial


Asunto(s)
Distribución por Edad , Vacuna contra la Varicela , Preescolar , Estudios Transversales , Susceptibilidad a Enfermedades , Emigración e Inmigración , Ensayo de Inmunoadsorción Enzimática , Factores de Riesgo , Estudios Seroepidemiológicos , Vacunación , Varicela
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA